"In the right context, treatment can be lifesaving, but in the wrong context, it can be quite harmful."

A new treatment for Lyme disease offers hope to patients who suffer from long-term effects of the bacterial infection, even after antibiotic treatment.

There are many ways to kill microbes that cause dangerous infections. Combining genetic screening with machine learning can help researchers identify new antimicrobials.

Most infection prevention guidelines center on the hospital environment rather than the patient. But the source of antibiotic-resistant microbes is often from the patient’s own body.

Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.

New research finds a key clue that sheds light on the spread and evolution of antibiotic resistance.

Researchers trying to harness electricity from bacteria realized they may be onto solving another issue: antibiotic resistance.

The Nobel Prize-winning Luria−Delbrück experiment showed that random mutations in bacteria can allow them to develop resistance by chance.

Researchers have found a virus kills "sleeping" bacteria. The discovery could help fight germs that can't be treated with antibiotics alone.

These compounds can kill methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that causes deadly infections.